Our previous studies found that IGF-1R was also highly expressed in esophageal cancer, and the bispecific fusion protein targeting EGFR and IGF-1R that we constructed had very significant inhibitory activity against esophageal cancer in vitro and in vivo [11]. This evidence concerns the gene EGFR and esophageal cancer.